Lenacapavir shows promise for long-acting HIV treatment and prevention.

The week of March 6 – March 10, 2021 I had the privilege of attending the Conference on Retroviruses and Opportunistic Infections (CROI).

The Rapid Start and PrEP program in Oklahoma is part of the federal “Ending the HIV Epidemic” initiative.

The new Avita pharmacy specializes in services related to HIV, PrEP, LGBTQ issues and the 340B Drug Pricing Program.

A single dose of the HIV capsid inhibitor reduced viral load in highly treatment-experienced people.

A study presented at the Conference on Retroviruses and Opportunistic Infections finds a disturbing disparity.

A next-generation implant maintained adequate drug levels for at least a year in an early study.

Black and Latino bisexual adults in this small survey had the lowest confidence in accessing HIV care and prevention services.

Black cisgender people are likelier than whites to be offered services for their partners—but the same isn’t true for Black trans people.

Charles Sanchez is the Mad Hatter of the HIV community, and this is the proof.